Synthesis, Anticancer Activity, and Preliminary Pharmacokinetic Evaluation of 4,4-Disubstituted Curcuminoid 2,2-bis(Hydroxymethyl)Propionate Derivatives

Compound <b>1</b> is a curcumin di-<i>O</i>-2,2-bis(hydroxymethyl)propionate that shows significant in vitro and in vivo inhibitory activity against MDA-MB-231 cells with eight to ten-fold higher potency than curcumin. Here, we modified the &#945;-position (C-4 position)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Der-Yen Lee, Yu-Chi Hou, Jai-Sing Yang, Hui-Yi Lin, Tsu-Yuan Chang, Kuo-Hsiung Lee, Sheng-Chu Kuo, Min-Tsang Hsieh
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2020-01-01
Series:Molecules
Assuntos:
curcuminoid derivatives
prodrug
colon cancer
breast cancer
active metabolites
Acceso en liña:https://www.mdpi.com/1420-3049/25/3/479
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares